how do glp 1 agonists work Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review What is GLP-1 & Does

Disclaimer: This content is for educational purposes only and is not a substitute for professional medical advice

DiMarchi had just left Lilly after working there for 22 years where he and Tschp had first met

December 2, 2025: Australian Government Issues Warning About Ozempic and Reports of Suicidality, Self-Harm The Therapeutic Goods Administration in Australia (a government agency similar to the FDA in the U.S.) warns that a concerning number of patients who take Ozempic and other GLP-1s reported suicidal ideation and self-harm

Diabetes Care 2011;34:9095

10.1038/s41433-023-02908-y [DOI] [PMC free article] [PubMed] [Google Scholar] 101.Heckel B (2024) Idiopathic intracranial hypertension after Abrupt Cessation of Medication: a Case Report of Abrupt Glucagon-Like Peptide-1 (GLP-1) receptor Agonist Cessation and Review of the literature

In the CNS, GLP-1s may impact neuronal function in conditions, such as Alzheimer's disease and Parkinson's disease, through multiple mechanisms